Streetbeat News

Equity Actions

SBIG

Cannabis marketing platform SpringBig Holdings (NASDAQ:SBIG) has closed a $4 million public equity offering, raising approximately $3 million in gross cash proceeds. The company's Q2 2023 financial projections expect revenue between $7.3 million and $7.6 million, representing 15% YoY growth.

Portfolio Pulse from Jelena Martinovic

June 01, 2023 | 4:33 pm

PRSO

Peraso announced a $4 million registered direct offering, causing its shares to trade lower.

Portfolio Pulse from Benzinga Newsdesk

June 01, 2023 | 3:17 pm

PRSO

Peraso announced a $4M registered direct offering priced at-the-market under Nasdaq rules.

Portfolio Pulse from Benzinga Newsdesk

June 01, 2023 | 3:15 pm

OCS

Oculis Holding announced the pricing of a $40.25 million public offering of ordinary shares, causing its shares to trade lower.

Portfolio Pulse from Benzinga Newsdesk

June 01, 2023 | 2:42 pm

OCS

Oculis has priced its 3.5 million share offering at $11.50 per share, raising capital for the company.

Portfolio Pulse from Benzinga Newsdesk

June 01, 2023 | 2:35 pm

PMTS

CPI Card Group Inc. (PMTS) is set to join the Russell 3000 Index, which measures the performance of the largest 3000 U.S. companies by market capitalization.

Portfolio Pulse from Benzinga Newsdesk

June 01, 2023 | 1:32 pm

VNRX

VolitionRx Limited (NYSE:VNRX) has priced an underwritten public offering of 13 million shares of common stock at $1.27 per share, expecting to raise $16.5 million in gross proceeds. The company plans to use the funds for research, product development, clinical studies, commercialization, working capital, and potential strategic acquisitions.

Portfolio Pulse from Happy Mohamed

June 01, 2023 | 1:30 pm

VNRX

VolitionRx Limited has announced the pricing of its $16.5 million public offering at $1.27 per share. The company plans to use the proceeds for general corporate purposes.

Portfolio Pulse from Benzinga Newsdesk

June 01, 2023 | 1:27 pm

T

T Stamp shares are trading lower after the company announced the pricing of a $2.9 million registered direct offering at $2.30 per share.

Portfolio Pulse from Benzinga Newsdesk

June 01, 2023 | 1:26 pm

LXRX

Lexicon Pharmaceuticals announced the pricing of a $125 million public offering and concurrent private placement, causing its shares to trade lower.

Portfolio Pulse from Benzinga Newsdesk

June 01, 2023 | 1:09 pm